Capstan Therapeutics is a startup based in the United States, most recent round Series B, 1 tracked investor.
Based in the United States, Capstan Therapeutics is a startup. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Capstan Therapeutics is a biotechnology company developing in vivo cell engineering therapeutics. They use targeted lipid nanoparticles to deliver mRNA payloads to specific cell types for treating various diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.